COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,050 Articles (22,627 medRxiv, 8,423 bioRxiv)

Most recent first Previous |  Page 2124: Articles 21231-21240  | Next

Cognitive deficits in people who have recovered from COVID-19 relative to controls: An N=84,285 online study
Hampshire, A., Trender, W., Chamberlain, S., Jolly, A., Grant, J. E., Patrick, F., Mazibuko, N., Williams, S., Barnby, J. M., Hellyer, P., Mehta, M. A.
10.1101/2020.10.20.20215863 — Posted: 2020-10-21 Discussion: Onsite
Prevalence of SARS-CoV-2 antibodies in France: results from nationwide serological surveillance
Le Vu, S., Jones, G., Anna, F., Rose, T., Richard, J.-B., Bernard-Stoecklin, S., Goyard, S., Demeret, C., Helynck, O., Robin, C., Monnet, V., Perrin de Facci, L., Ungeheuer, M.-N., Leon, L., Guillois, Y., Filleul, L., Charneau, P., Levy-Bruhl, D., van der Werf, S., Noel, H.
10.1101/2020.10.20.20213116 — Posted: 2020-10-21
Prevalence of SARS-CoV-2 IgG antibodies in a population from Veracruz (Southeastern Mexico).
Remes-Troche, J. M., Ramos-de-la-Medina, A., Manriquez-Reyes, M., Martinez-Perez Maldonado, L., Solis-Gonzalez, M. A., Hernandez-Flores, K., Vivanco-Cid, H.
10.1101/2020.10.19.20215558 — Posted: 2020-10-21
Tocilizumab is associated with reduction in inflammation and improvement in P/F ratio in critically sick COVID19 patients
Rana, M. A., Hashmi, M. S., Saif, M. M. U., Munir, M. F., Qayyum, A., Pervaiz, R., Hafeez, M. M.
10.1101/2020.10.20.20210195 — Posted: 2020-10-21
Characteristics and outcomes of clinically diagnosed RT-PCR swab negative COVID-19: a retrospective cohort study
Middleton, P., Perez-Guzman, P. N., Cheng, A., Kumar, N., Kont, M., Daunt, A., Mukherjee, S., Cooke, G., Hallett, T. B., Hauck, K. D., White, P. J., Thursz, M. R., Nayagam, S.
10.1101/2020.10.20.20204651 — Posted: 2020-10-21
Clinical symptoms among ambulatory patients tested for SARS-CoV-2
Chung, J., Kim, S. S., Jackson, M. L., Jackson, L. A., Belongia, E. A., King, J. P., Zimmerman, R. K., Nowalk, M. P., Martin, E. T., Monto, A., Gaglani, M., Smith, M. E., Patel, M., Flannery, B.
10.1101/2020.10.20.20213272 — Posted: 2020-10-21
An agent-based model of spread of a pandemic with validation using COVID-19 data from New York State
Datta, A., Winkelstein, P., Sen, S.
10.1101/2020.10.19.20215517 — Posted: 2020-10-21
Could nutrition modulate COVID-19 susceptibility and severity of disease? A systematic review
James, P. T., Ali, Z., Armitage, A. E., Bonell, A., Cerami, C., Drakesmith, H., Jobe, M., Jones, K. S., Liew, Z., Moore, S. E., Morales-Berstein, F., Nabwera, H., Nadjm, B., Pasricha, S.-R., Scheelbeek, P., Silver, M. J., Teh, M. R., Prentice, A. M.
10.1101/2020.10.19.20214395 — Posted: 2020-10-21
Changes of evening exposure to electronic devices during the COVID-19 lockdown affect the time course of sleep disturbances
Salfi, F., Amicucci, G., Corigliano, D., D'Atri, A., Viselli, L., Tempesta, D., Ferrara, M.
10.1101/2020.10.20.20215756 — Posted: 2020-10-21
Analytical solution of equivalent SEIR and agent-based model of COVID-19; showing the bounds of contact tracing
Tunc, H., Sari, F. Z., Darendeli, B., Nashebi, R., Sari, M., Kotil, S. E.
10.1101/2020.10.20.20212522 — Posted: 2020-10-21

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).